In Spring 2020, the AACPDM Board approved a process developed by the AACPDM Advocacy Committee for quick review and response of information that include formal policies, position statements, legislation, or issues or concerns that relate to advocacy for persons with cerebral palsy or other related childhood onset disability, their families, providers who serve them and or related research or educational concerns.
View recent items that have been approved.
Date posted: May 4, 2021
CP Collaborative Sends Letter Encouraging CP Research in the FY 2022 Appropriations Bill for the Centers for Disease Control (CDC) and National Institutes of Health (NIH). Read the letter HERE.
Date posted: March 18, 2021
Please view the March edition of “Disability Scoop” and the article entitled, “CDC Urged To Prioritize COVID-19 Vaccines For People With Developmental Disabilities”
AACPDM was proud to partner with 16 other organizations to send the letter that can be viewed HERE and was spearheaded by the American Academy of Developmental Medicine and Dentistry.
Date posted: January, 2021
The AADMD developed a statement regarding vaccine distribution and allocation. The statement expresses that distribution must be done in a safe and equitable manner, and individuals with intellectual and developmental disabilities (IDD) must be explicitly addressed in any framework for vaccine allocation.
Date posted: December, 2020
ASHA provides a listing of the Medicaid practices across the US and provides an example letter to advocate at the state level for reimbursement of telehealth for Audiology and Speech providers. This important as our patients benefit from receiving these services in the community.
Date posted: October, 2020
